Back to all stocks

KVUE

9/9 Score

Kenvue Inc.

Analysis Date: May 8, 2026

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Buffettology Criteria

All 9 of 9 criteria passed

  • High ROE

    Return on Equity > 12%

    Value: 15.2%

  • High ROIC

    Return on Invested Capital > 9%

    Value: 9.5%

  • Cash Machine

    FCF / Assets > 5%

    Value: 0.06

  • Fair Valuation

    Earnings Yield > 3.5%

    Value: 4.8%

  • Share Buybacks

    Share Count is Dropping

    Value: 0.1%

  • Defensible Moat

    Gross Profit Margin > 40%

    Value: 58.4%

  • Simple Business

    Not in a speculative sector (e.g., Biotech)

    Value: Consumer Defensive

  • Conservative Debt

    Debt to Equity < 1.5

    Value: 0.82x

  • Consistent Growth

    5-Year Growth is Positive

    Value: 2.6%

Want More Analysis?

Get detailed scores for thousands of stocks and discover your next investment with the Vetted app.

Download Vetted